A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities
1Laboratory for Experimental and Applied Pharmacokinetics and Pharmacodynamics, Department of Pharmacy, National University of Singapore, 19 Science Drive, Singapore.
Biomaterials
|June 26, 2010
Summary
This study developed a dual-drug nanocapsule for sequential delivery of combretastatin A4 and paclitaxel. This engineered nanocapsule shows promise for combinatorial cancer therapy by targeting tumor neovasculature and cancer cells.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Developing effective drug delivery systems is crucial for cancer therapy.
- Sequential drug release can optimize therapeutic outcomes by targeting different aspects of cancer progression.
Purpose of the Study:
- To engineer a nanocapsule for sequential delivery of combretastatin A4 (CA4) and paclitaxel (PTX).
- To evaluate the therapeutic efficacy of this dual-drug nanocapsule in preclinical cancer models.
Main Methods:
- Fabrication of a nanocapsule encapsulating CA4 within a PTX-conjugated amphiphilic polyester matrix.
- Characterization of nanocapsule size, drug release kinetics, cellular uptake, and in vivo biodistribution.
- Assessment of therapeutic effects in pro-angiogenesis models, tumor xenografts, and liver metastasis experiments.
Main Results:
- The nanocapsule (68 nm) demonstrated efficient cellular uptake and sequential release of CA4 and PTX.
- In vivo studies showed preferential tumor accumulation, long circulation, tumor vasculature disruption, inhibited proliferation, and induced apoptosis.
- The nanocapsule also demonstrated capacity for preventing liver metastasis.
Conclusions:
- The dual-drug nanocapsule with sequential release capability is a promising candidate for combinatorial cancer therapy.
- This nanocapsule design may offer a new strategy for cancer treatment and diagnosis.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...